QR Kod

A Distinctive Metabolomics Pattern Associated with the Administration of Combined Sacubitril/Valsartan to Healthy Subjects: A Kinetic Approach

<b>Background/Objective:</b> Sacubitril/Valsartan are a combination drug approved for heart failure treatment, known to enhance natriuretic peptide activity and inhibit the renin–angiotensin–aldosterone system (RAAS). While its clinical efficacy is well-established, its broader impact on human metab...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Randh AlAhmari, Hana M. A. Fakhoury, Reem AlMalki, Hatouf H. Sukkarieh, Lina Dahabiyeh, Tawfiq Arafat, Anas M. Abdel Rahman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2025-08-01
Seri Bilgileri:Pharmaceuticals
Konular:
Sacubitril/Valsartan
metabolomics
LC-QToF HRMS
pyrimidine metabolism
pharmacokinetics
uridine triphosphate
Online Erişim:https://www.mdpi.com/1424-8247/18/9/1264
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller